USP10:朋友和敌人
Aart G Jochemsen1, Yosef Shiloh
1Department of Molecular Cell Biology, Leiden University Medical Center, 2300RC Leiden, The Netherlands. a.g.jochemsen@lumc.nl
Cell
|February 11, 2010
概括
研究人员发现USP10,一种二基化蛋白酶,调节瘤抑制蛋白p53. 这一发现对于理解DNA损伤反应和瘤发育至关重要.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 生物化学 生物化学
背景情况:
- 瘤抑制蛋白p53对于DNA损伤反应至关重要.
- 主要通过全方位化来调节p53的活性.
- 了解p53调节是癌症发展研究的关键.
研究的目的:
- 在DNA损伤反应中识别p53的新型调节剂.
- 调查duebiquitinating蛋白酶在p53调节中的作用.
- 探索p53调节对瘤发展的影响.
主要方法:
- 研究了USP10和p53.3之间的相互作用.
- 评估了USP10对p53无处不在水平的影响.
- 在细胞模型中检查了USP10介导的p53调节的功能后果.
主要成果:
- 确定USP10作为一个直接与p53.3相互作用的deubiquitinating蛋白酶.
- 证明USP10二基化p53,影响其稳定性和活性.
- 展示了USP10在通过p53调节调节DNA损伤反应途径中的作用.
结论:
- USP10是瘤抑制蛋白p53.3的一个新发现的调节器.
- USP10影响DNA损伤反应,对瘤发育有影响.
- 针对USP10可能为癌症治疗提供新的治疗策略.
相关概念视频
Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
Sympathetic Signaling
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Friendships and Close Friendships
Friendship formation is a dynamic process shaped by psychological, cultural, and social factors. Friendships play a crucial role in emotional well-being, social development, and personal identity from childhood to adulthood.Childhood and Early FriendshipsFriendships in childhood often arise due to shared environments, such as school or neighborhood interactions. At this stage, proximity and common interests serve as the primary basis for connection. As children grow, their friendships evolve...


